Cabaletta Bio (CABA) Depreciation & Amortization (CF) (2019 - 2025)
Cabaletta Bio (CABA) recorded quarterly Depreciation & Amortization (CF) of $348000.0 in Q4 2025, up 0.87% quarter-over-quarter from $345000.0 in Q3 2025, and down 25.64% on a YoY basis from $468000.0 in Q4 2024.
Cabaletta Bio (CABA) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
Cabaletta Bio's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $348000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) fell 25.64% year-over-year to $348000.0; the TTM figure through Dec 2025 stood at $1.6 million (down 3.8% YoY), while the FY2025 annual figure was $1.6 million, down 3.8% from the prior year.
- Depreciation & Amortization (CF) was $348000.0 for Q4 2025 at Cabaletta Bio, up from $345000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $485000.0 in Q1 2025 to a low of $116000.0 in Q1 2021.
- Historically, Depreciation & Amortization (CF) has averaged $334700.0 across 5 years, with a median of $356500.0 in 2022.
- The sharpest annual moves came in 2021 and 2025: Depreciation & Amortization (CF) soared 145.56% in 2021, then declined 25.64% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $234000.0 in 2021, then jumped by 52.99% to $358000.0 in 2022, then fell by 6.15% to $336000.0 in 2023, then soared by 39.29% to $468000.0 in 2024, then slipped by 25.64% to $348000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $348000.0 (Q4 2025), $345000.0 (Q3 2025), and $468000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | 348,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 348,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 485,000.00 |
| Mar 31, 2025 | 485,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Sep 30, 2023 | 355,000.00 |
| Sep 30, 2023 | 355,000.00 |